These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27108947)

  • 1. Novel approaches to targeting PDE3 in cardiovascular disease.
    Movsesian M
    Pharmacol Ther; 2016 Jul; 163():74-81. PubMed ID: 27108947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective regulation of cyclic nucleotide phosphodiesterase PDE3A isoforms.
    Vandeput F; Szabo-Fresnais N; Ahmad F; Kho C; Lee A; Krall J; Dunlop A; Hazel MW; Wohlschlegel JA; Hajjar RJ; Houslay MD; Manganiello VC; Movsesian MA
    Proc Natl Acad Sci U S A; 2013 Dec; 110(49):19778-83. PubMed ID: 24248367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA2) activity by phosphodiesterase 3A (PDE3A) in human myocardium: phosphorylation-dependent interaction of PDE3A1 with SERCA2.
    Ahmad F; Shen W; Vandeput F; Szabo-Fresnais N; Krall J; Degerman E; Goetz F; Klussmann E; Movsesian M; Manganiello V
    J Biol Chem; 2015 Mar; 290(11):6763-76. PubMed ID: 25593322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2015 Nov; 88():29-38. PubMed ID: 26388264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New pharmacologic interventions to increase cardiac contractility: challenges and opportunities.
    Movsesian M
    Curr Opin Cardiol; 2015 May; 30(3):285-91. PubMed ID: 25807221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.
    Qvigstad E; Moltzau LR; Aronsen JM; Nguyen CH; Hougen K; Sjaastad I; Levy FO; Skomedal T; Osnes JB
    Cardiovasc Res; 2010 Mar; 85(4):763-72. PubMed ID: 19900965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDE3 inhibition in dilated cardiomyopathy: reasons to reconsider.
    Movsesian MA
    J Card Fail; 2003 Dec; 9(6):475-80. PubMed ID: 14966789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing hearts.
    Meier S; Andressen KW; Aronsen JM; Sjaastad I; Hougen K; Skomedal T; Osnes JB; Qvigstad E; Levy FO; Moltzau LR
    Eur J Pharmacol; 2017 Oct; 812():174-183. PubMed ID: 28697992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 Inhibition.
    Hashimoto T; Kim GE; Tunin RS; Adesiyun T; Hsu S; Nakagawa R; Zhu G; O'Brien JJ; Hendrick JP; Davis RE; Yao W; Beard D; Hoxie HR; Wennogle LP; Lee DI; Kass DA
    Circulation; 2018 Oct; 138(18):1974-1987. PubMed ID: 30030415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDE3 cyclic nucleotide phosphodiesterases and the compartmentation of cyclic nucleotide-mediated signalling in cardiac myocytes.
    Movsesian MA
    Basic Res Cardiol; 2002; 97 Suppl 1():I83-90. PubMed ID: 12479240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of C-type natriuretic peptide-induced cGMP and functional responses by PDE2 and PDE3 in failing myocardium.
    Moltzau LR; Meier S; Aronsen JM; Afzal F; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
    Naunyn Schmiedebergs Arch Pharmacol; 2014 May; 387(5):407-17. PubMed ID: 24424715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phosphodiesterase 3 mediates cross-talk between the protein kinase- and cGMP- dependent pathways and cyclic AMP metabolism].
    Makuch E; Matuszyk J
    Postepy Hig Med Dosw (Online); 2012 Jul; 66():492-500. PubMed ID: 22922149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles.
    Afzal F; Andressen KW; Mørk HK; Aronsen JM; Sjaastad I; Dahl CP; Skomedal T; Levy FO; Osnes JB; Qvigstad E
    Br J Pharmacol; 2008 Dec; 155(7):1005-14. PubMed ID: 18846035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase types 3 and 4 regulate the phasic contraction of neonatal rat bladder smooth myocytes via distinct mechanisms.
    Zhai K; Chang Y; Wei B; Liu Q; Leblais V; Fischmeister R; Ji G
    Cell Signal; 2014 May; 26(5):1001-10. PubMed ID: 24463006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A PDE3A Promoter Polymorphism Regulates cAMP-Induced Transcriptional Activity in Failing Human Myocardium.
    Sucharov CC; Nakano SJ; Slavov D; Schwisow JA; Rodriguez E; Nunley K; Medway A; Stafford N; Nelson P; McKinsey TA; Movsesian M; Minobe W; Carroll IA; Taylor MRG; Bristow MR
    J Am Coll Cardiol; 2019 Mar; 73(10):1173-1184. PubMed ID: 30871701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
    Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
    Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cGMP-cAMP interplay in cardiac myocytes: a local affair with far-reaching consequences for heart function.
    Stangherlin A; Zaccolo M
    Biochem Soc Trans; 2012 Feb; 40(1):11-4. PubMed ID: 22260658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase inhibition in heart failure.
    Movsesian MA; Kukreja RC
    Handb Exp Pharmacol; 2011; (204):237-49. PubMed ID: 21695643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single inhibition of either PDE3 or PDE4 unmasks β2-adrenoceptor-mediated inotropic and lusitropic effects in the left but not right ventricular myocardium of rat.
    Soler F; Fernández-Belda F; Pérez-Schindler J; Hernández-Cascales J
    Eur J Pharmacol; 2015 Oct; 765():429-36. PubMed ID: 26364538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase 3A expression and activity in the murine vasculature is influenced by NO-sensitive guanylyl cyclase.
    Dünnes S; Voussen B; Aue A; Groneberg K; Nikolaev V; Groneberg D; Friebe A
    Pflugers Arch; 2018 Apr; 470(4):693-702. PubMed ID: 29294149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.